HomeCompareARZTY vs ARCC

ARZTY vs ARCC: Dividend Comparison 2026

ARZTY yields 26.70% · ARCC yields 10.65%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ARZTY wins by $84.7K in total portfolio value
10 years
ARZTY
ARZTY
● Live price
26.70%
Share price
$7.49
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$109.2K
Annual income
$13,054.20
Full ARZTY calculator →
ARCC
Ares Capital Corporation
● Live price
10.65%
Share price
$18.02
Annual div
$1.92
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$1.14
Full ARCC calculator →

Portfolio growth — ARZTY vs ARCC

📍 ARZTY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodARZTYARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ARZTY + ARCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ARZTY pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARZTY
Annual income on $10K today (after 15% tax)
$2,269.69/yr
After 10yr DRIP, annual income (after tax)
$11,096.07/yr
ARCC
Annual income on $10K today (after 15% tax)
$905.66/yr
After 10yr DRIP, annual income (after tax)
$0.97/yr
At 15% tax rate, ARZTY beats the other by $11,095.10/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARZTY + ARCC for your $10,000?

ARZTY: 50%ARCC: 50%
100% ARCC50/50100% ARZTY
Portfolio after 10yr
$66.9K
Annual income
$6,527.67/yr
Blended yield
9.76%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

ARZTY
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
2.7
Piotroski
7/9
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+21.4% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARZTY buys
0
ARCC buys
13
PoliticianChamberTickerTypeAmountDate
John Fetterman🏛 Senate$ARCC▲ Buy$1,001 - $15,0002025-09-09
John Fetterman🏛 Senate$ARCC▼ Sell$1,001 - $15,0002025-09-04
Ashley Moody🏛 Senate$ARCC▲ Buy$15,001 - $50,0002025-04-04
John Fetterman🏛 Senate$ARCC▲ Buy$1,001 - $15,0002025-02-18
Dave McCormick🏛 Senate$ARCC▲ Buy$250,001 - $500,0002025-01-17
Pete Sessions🏢 House$ARCC▼ Sell$1,001 - $15,0002023-11-01
Pete Sessions🏢 House$ARCC▲ Buy$569.252023-10-06
Pete Sessions🏢 House$ARCC▲ Buy$0 - $1,0002023-10-06
Pete Sessions🏢 House$ARCC▲ Buy$155.922023-08-15
Pete Sessions🏢 House$ARCC▲ Buy$0 - $1,0002023-08-15
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricARZTYARCC
Forward yield26.70%10.65%
Annual dividend / share$2.00$1.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$109.2K$24.5K
Annual income after 10y$13,054.20$1.14
Total dividends collected$71.1K$1.1K
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusBuyBuy

Year-by-year: ARZTY vs ARCC ($10,000, DRIP)

YearARZTY PortfolioARZTY Income/yrARCC PortfolioARCC Income/yrGap
1← crossover$13,370$2,670.23$11,373$532.74+$2.0KARZTY
2$17,643$3,336.59$12,608$279.46+$5.0KARZTY
3$22,993$4,114.78$13,809$142.90+$9.2KARZTY
4$29,614$5,011.68$15,042$72.20+$14.6KARZTY
5$37,719$6,032.61$16,341$36.27+$21.4KARZTY
6$47,541$7,181.12$17,732$18.18+$29.8KARZTY
7$59,327$8,458.84$19,231$9.10+$40.1KARZTY
8$73,346$9,865.45$20,851$4.55+$52.5KARZTY
9$89,879$11,398.64$22,605$2.28+$67.3KARZTY
10$109,224$13,054.20$24,504$1.14+$84.7KARZTY

ARZTY vs ARCC: Complete Analysis 2026

ARZTYStock

ARYZTA AG provides frozen B2B baking solutions in Europe, Asia, Australia, and New Zealand. It offers pastries, cookies, donuts, muffins, buns, bread rolls and artisan loaves, sweet baked and morning goods, and savory and other products. The company also provides asset management services; and distributes food products. It serves large retail, convenience, and independent retailers, as well as quick service restaurants and other foodservice customers. In addition, it sells product under the Hiestaud, Mette Munk, Pre Pain, Cuisine de France, Coup de Pates, La Brea, Oits Spunkmeyer, and Fornetti brands. The company has 26 bakeries in 27 countries. ARYZTA AG was founded in 1897 and is based in Schlieren, Switzerland.

Full ARZTY Calculator →

ARCCBDC

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Full ARCC Calculator →
📬

Get this ARZTY vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARZTY vs SCHDARZTY vs JEPIARZTY vs OARZTY vs KOARZTY vs MAINARZTY vs HTGCARZTY vs GBDCARZTY vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.